Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Ecancermedicalscience|September 27, 2021
Real-world results of definitive chemoradiation in carcinoma oesophagus: can SCOPE1 results be replicated outside trial setting?Tapesh Bhattacharyya, Vishnu Harilal, Rohit Sashidharan, et al.
Trials|April 22, 2026
NEO-HYPORT: does neoadjuvant radiotherapy improve breast cancer outcomes? An open label, randomised, parallel group, superiority trial to compare the disease-free survival following neoadjuvant versus adjuvant hypofractionated radiotherapy in breast cancer (NEO-HYPORT)Sanjoy Chatterjee, Santam Chakraborty, Rosina Ahmed, et al.
Indian Journal of Surgical Oncology|March 25, 2020
Presentation and Management of Dermatofibrosarcoma Protuberans: a Single Center ProtocolHarish Verma, Karan Sehgal, Karnav B Panchal, et al.
Head & Neck|December 16, 2018
Influence of comorbidity on therapeutic decision making and impact on outcomes in patients with head and neck squamous cell cancers: Results from a prospective cohort studyJaiPrakash Agarwal, Deepanjali Adulkar, Monali Swain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2026
Impact of ultrahypofractionated adjuvant regional nodal radiotherapy on patient-reported quality of life: the HYPORT adjuvant trial (NCT03788213)Santam Chakraborty, Sanjoy Chatterjee, Patricia S, et al.
Head & Neck|March 26, 2024
Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimenSaheli Saha, Indranil Mallick, Prattusha Mukherjee, et al.
Brachytherapy|June 11, 2017
Income generated by women treated with magnetic resonance imaging-based brachytherapy: A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare settingSantam Chakraborty, Umesh Mahantshetty, Supriya Chopra, et al.
BMJ Open|April 16, 2026
Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) used in ambulatory palliative care for adult patients with cancer in low-income and middle-income countries: a systematic review protocolMebin Mathew, Arun Ghoshal, Johnblack K Kabukye, et al.
JCO Global Oncology|June 10, 2026
Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 PandemicVenkata Krishna Vamsi Gade, Jyoti Sharma, Sougata Maity, et al.
South Asian Journal of Cancer|June 9, 2016
An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patientsVijay M Patil, Santam Chakraborty, T K Jithin, et al.
Pageof 5